Cited by

• Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis.

  Breitkopf SB, Yuan M, Helenius KP, Lyssiotis CA, Asara JM. Breitkopf SB, et al. Anal Chem. 2015 Nov 3;87(21):10995-1006. doi: 10.1021/acs.analchem.5b03040. Epub 2015 Oct 12. Anal Chem. 2015. PMID: 26434776 Free PMC article.
• Expression and cellular distribution of ubiquitin in response to injury in the developing spinal cord of Monodelphis domestica.

  Noor NM, Møllgård K, Wheaton BJ, Steer DL, Truettner JS, Dziegielewska KM, Dietrich WD, Smith AI, Saunders NR. Noor NM, et al. PLoS One. 2013 Apr 23;8(4):e62120. doi: 10.1371/journal.pone.0062120. Print 2013. PLoS One. 2013. PMID: 23626776 Free PMC article.
• Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma.

  Zhang C, Kuo JC, Huang Y, Hu Y, Deng L, Yung BC, Zhao X, Zhang Z, Pan J, Ma Y, Lee RJ. Zhang C, et al. Pharmaceutics. 2023 Nov 25;15(12):2674. doi: 10.3390/pharmaceutics15122674. Pharmaceutics. 2023. PMID: 38140015 Free PMC article.
• Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma.

  Vasuthasawat A, Yoo EM, Trinh KR, Lichtenstein A, Timmerman JM, Morrison SL. Vasuthasawat A, et al. MAbs. 2016 Oct;8(7):1386-1397. doi: 10.1080/19420862.2016.1207030. Epub 2016 Jun 30. MAbs. 2016. PMID: 27362935 Free PMC article.
• Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles.

  Borisov N, Sergeeva A, Suntsova M, Raevskiy M, Gaifullin N, Mendeleeva L, Gudkov A, Nareiko M, Garazha A, Tkachev V, Li X, Sorokin M, Surin V, Buzdin A. Borisov N, et al. Front Oncol. 2021 Apr 15;11:652063. doi: 10.3389/fonc.2021.652063. eCollection 2021. Front Oncol. 2021. PMID: 33937058 Free PMC article.